Robert Elsby
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 14
-
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Katherine S. Fenner (5 shared papers)Dominic D. Surry (9 shared papers)Constanze Hilgendorf (2 shared papers)Neil R. Kitteringham (4 shared papers)Pradeep Kumar Sharma (7 shared papers)Christopher E. Goldring (2 shared papers)James L. Maggs (3 shared papers)John Ashby (3 shared papers)
- Journals
- Xenobiotica (3 papers)Drug Metabolism and Disposition (3 papers)European Journal of Pharmaceutical Sciences (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Robert Elsby
26 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 78
- Pharmacology 690
- Oncology 567
- Health, Toxicology and Mutagenesis 138
- Molecular Biology 206
- Surgery 125
Countries citing papers authored by Robert Elsby
This map shows the geographic impact of Robert Elsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Elsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Elsby more than expected).
Fields of papers citing papers by Robert Elsby
This network shows the impact of papers produced by Robert Elsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Elsby. The network helps show where Robert Elsby may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Elsby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 207 | |
| 2 | 2004 | 178 | |
| 3 | 2012 | 174 | |
| 4 | 2003 | 136 | |
| 5 | 2015 | 133 | |
| 6 | 2015 | 116 | |
| 7 | 2008 | 113 | |
| 8 | 2001 | 99 | |
| 9 | 2015 | 85 | |
| 10 | 2006 | 62 | |
| 11 | 2012 | 48 | |
| 12 | 2016 | 40 | |
| 13 | 2017 | 40 | |
| 14 | 2000 | 36 | |
| 15 | 2003 | 35 | |
| 16 | 2001 | 32 | |
| 17 | 2011 | 31 | |
| 18 | 2009 | 26 | |
| 19 | 2011 | 26 | |
| 20 | 2013 | 21 |
About Robert Elsby
Robert Elsby is a scholar working on Oncology, Pharmacology, Health, Toxicology and Mutagenesis, Molecular Biology and Spectroscopy, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (7 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Glutathione Transferases and Polymorphisms (2 papers), Estrogen and related hormone effects (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper), Advanced Proteomics Techniques and Applications (1 paper) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Pharmacology (690 citations), Oncology (567 citations), Health, Toxicology and Mutagenesis (138 citations), Molecular Biology (206 citations) and Surgery (125 citations). Robert Elsby has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Katherine S. Fenner, Dominic D. Surry, Constanze Hilgendorf, Neil R. Kitteringham, Pradeep Kumar Sharma, Christopher E. Goldring, James L. Maggs, John Ashby, Bruce K. Birmingham and B. Kevin Park. Their work appears in journals such as Xenobiotica, Drug Metabolism and Disposition, European Journal of Pharmaceutical Sciences, Journal of Pharmacology and Experimental Therapeutics and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.